Research progress on the regulation of HBx on lncRNA in the development of HCC

TIAN Xu-yun, LIU Lin, ZENG Yi, LUO Hao-xiang

PDF(613 KB)
Welcome to Current Immunology, Today is May. 9, 2025
PDF(613 KB)
Current Immunology ›› 2025, Vol. 45 ›› Issue (1) : 82-88.

Research progress on the regulation of HBx on lncRNA in the development of HCC

  • TIAN Xu-yun1, 2, 3, LIU Lin1, 2, 3, ZENG Yi1, 2, 3, LUO Hao-xiang1, 2, 3
Author information +
History +

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignancies, and the main risk factor for HCC is HBV infection. Hepatitis B virus X protein (HBx) is a key regulator of HBV-associated HCC and can promote tumorigenesis. It has been reported that many long non-coding RNA (lncRNA) contribute to the HCC development, mainly by promoting HBV replication, up-regulating oncogenes expression, or down-regulating the expression of tumor suppressors.Some lncRNA can also act directly as tumor suppressors, which have been extensively studied as disease-treating targets.In this review, we will discuss the role of HBx-regulated lncRNA in HBV-induced HCC and summarize the mechanisms of tumorigenesis and the development of cancer.

Key words

hepatocellular carcinoma / long non-coding ribonucleic acid / hepatitis B virus / hepatitis B virus X protein

Cite this article

Download Citations
TIAN Xu-yun, LIU Lin, ZENG Yi, LUO Hao-xiang. Research progress on the regulation of HBx on lncRNA in the development of HCC. Current Immunology. 2025, 45(1): 82-88
PDF(613 KB)

283

Accesses

0

Citation

Detail

Sections
Recommended

/